Osarogiagbon, R. U., Hsu, R., Hsu, M. L., Patel, S. P., Smeltzer, M. P., Ursino, G., Lupicka, M., Rattigan-Brown, Y., Arslan, I., Baser, E., Stokes, M., Gosh, R., Pettersson, C., Liang, Y., Sandelin, M., Salomonsen, R. (2025). Real-world (rw) study to identify disparities in outcomes for patients (pts) with early-stage resected NSCLC who received biomarker-targeted adjuvant treatment (BTRx).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8071